These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8275932)

  • 41. 38-Amino acid form of pituitary adenylate cyclase activating peptide induces process outgrowth in human neuroblastoma cells.
    Deutsch PJ; Schadlow VC; Barzilai N
    J Neurosci Res; 1993 Jun; 35(3):312-20. PubMed ID: 8102409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigation and characterization of receptors for pituitary adenylate cyclase-activating polypeptide in human brain by radioligand binding and chemical cross-linking.
    Suda K; Smith DM; Ghatei MA; Murphy JK; Bloom SR
    J Clin Endocrinol Metab; 1991 May; 72(5):958-64. PubMed ID: 1673686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
    Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
    J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) on the spontaneous release of acetylcholine from the rat hippocampus by brain microdialysis.
    Masuo Y; Matsumoto Y; Tokito F; Tsuda M; Fujino M
    Brain Res; 1993 May; 611(2):207-15. PubMed ID: 8334515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of pituitary adenylate cyclase-activating polypeptide on hormone secretion by human pituitary adenomas in vitro.
    Desai BJ; Monson JP; Holdstock JG; Aylwin SJ; Geddes JF; Wood DF; Burrin JM
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1771-7. PubMed ID: 7527412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system.
    Mounien L; Do Rego JC; Bizet P; Boutelet I; Gourcerol G; Fournier A; Brabet P; Costentin J; Vaudry H; Jégou S
    Neuropsychopharmacology; 2009 Jan; 34(2):424-35. PubMed ID: 18536705
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of endogenous sympathetic neuron pituitary adenylate cyclase-activating polypeptide (PACAP): depolarization regulates production and secretion through induction of multiple propeptide transcripts.
    Brandenburg CA; May V; Braas KM
    J Neurosci; 1997 Jun; 17(11):4045-55. PubMed ID: 9151721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuropeptide regulation of interleukin-6 production from the pituitary: stimulation by pituitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide.
    Tatsuno I; Somogyvari-Vigh A; Mizuno K; Gottschall PE; Hidaka H; Arimura A
    Endocrinology; 1991 Oct; 129(4):1797-804. PubMed ID: 1655384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pituitary adenylate cyclase-activating polypeptides (PACAP27 and PACAP38) inhibit the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMP.
    Delgado M; De la Fuente M; Martínez C; Gomariz RP
    J Neuroimmunol; 1995 Nov; 62(2):137-46. PubMed ID: 7499501
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Frog vasoactive intestinal polypeptide and galanin: primary structures and effects on pituitary adenylate cyclase.
    Chartrel N; Wang Y; Fournier A; Vaudry H; Conlon JM
    Endocrinology; 1995 Jul; 136(7):3079-86. PubMed ID: 7540547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytochemical characterization of anterior pituitary target cells for the neuropeptide, pituitary adenylate cyclase activating polypeptide (PACAP), using biotinylated ligands.
    Vigh S; Arimura A; Gottschall PE; Kitada C; Somogyvári-Vigh A; Childs GV
    Peptides; 1993; 14(1):59-65. PubMed ID: 8441707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
    Cavallaro S; Copani A; D'Agata V; Musco S; Petralia S; Ventra C; Stivala F; Travali S; Canonico PL
    Mol Pharmacol; 1996 Jul; 50(1):60-6. PubMed ID: 8700120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors.
    Lundberg P; Lundgren I; Mukohyama H; Lehenkari PP; Horton MA; Lerner UH
    Endocrinology; 2001 Jan; 142(1):339-47. PubMed ID: 11145597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The 38-amino acid form of pituitary adenylate cyclase-activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth.
    Deutsch PJ; Sun Y
    J Biol Chem; 1992 Mar; 267(8):5108-13. PubMed ID: 1312085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancement of phagocytosis in mouse macrophages by pituitary adenylate cyclase activating polypeptide (PACAP) and related peptides.
    Ichinose M; Asai M; Imai K; Sawada M
    Immunopharmacology; 1995 Sep; 30(3):217-24. PubMed ID: 8557521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The stimulatory effects and binding characteristics of PACAP27 in rat dispersed pancreatic acini.
    Kashimura J; Shimosegawa T; Iguchi K; Mochizuki T; Yanaihara N; Koizumi M; Toyota T
    Tohoku J Exp Med; 1993 Nov; 171(3):243-54. PubMed ID: 7512757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.